Optimal Management of Hereditary Angioedema: Shared Decision-Making

All patients with hereditary angioedema (HAE) must have access to on-demand therapy to treat attacks and may benefit from prophylactic therapy to reduce the attack frequency. Treatment decisions should be individualized, based on patient preferences and needs. One method for facilitating individuali...

Descripción completa

Detalles Bibliográficos
Autores principales: Banerji, Aleena, Anderson, John, Johnston, Douglas T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881782/
https://www.ncbi.nlm.nih.gov/pubmed/33603408
http://dx.doi.org/10.2147/JAA.S284029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881782/
https://www.ncbi.nlm.nih.gov/pubmed/33603408
http://dx.doi.org/10.2147/JAA.S284029

Ejemplares similares